Linda Llewelyn - Oct 16, 2023 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role: Chief People Officer
Signature: /s/Benjamin Landry, as Attorney-in-Fact
Stock symbol: HCAT
Transactions as of: Oct 16, 2023
Transactions value $: -$9,671
Form type: 4
Date filed: 10/20/2023, 04:04 PM
Previous filing: Sep 19, 2023
Next filing: Nov 17, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCAT	Common Stock	Sale	-$9.67K	-1.16K	-1.44%	$8.33	79.7K	Oct 16, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 23, 2023 in accordance with Rule 10b5-1.